NeuronFeed Submit a startup
Startups/ AI Healthcare/ Recursion

Recursion

Pioneering AI-driven solutions in drug discovery to radically improve lives.

United States Founded 2013
Visit website
NeuronScore 36/100
Agent-Ready 5/100 MCP, API, SDKs
Pricing Enterprise
Status Active
Team 501-1000 since 2013
About Recursion

Recursion is a clinical-stage TechBio company decoding biology to industrialise drug discovery. They leverage AI, robotics, and a vast proprietary dataset to identify novel targets and design optimised molecules, aiming to reduce the high failure rate of traditional drug development. Their Recursion OS platform accelerates the discovery and development of potential first-in-class and best-in-class treatments for conditions with high unmet medical need.

NeuronScore Signal quality across funding, news, traction & verification
36 /100
Tracked
Funding momentum
0/30
Active deals
0/10
News
1/12
Traffic
0/8
Verified
18/20
Freshness
0/10
Agent-Ready Score 5/100 · checked May 2, 2026
MCP
Public API
Webhooks
OAuth2
SDK · TS
SDK · Py
Alternatives 6 similar All →
FAQ
When was Recursion founded?
Recursion was founded in 2013, United States.
How much does Recursion cost?
Recursion pricing: Enterprise · Contact sales.
Where is Recursion headquartered?
Recursion is headquartered in United States.
Discussion

Sign in to join the discussion.

Sign in →

No comments yet — be the first.

Contextual paths to related AI startups, deals and rankings.